Improving Medicaid Precision and Cancer Test Act of 2025

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 6320 Introduced in House (IH)]

<DOC>






119th CONGRESS
  1st Session
                                H. R. 6320

 To amend title XIX of the Social Security Act to require coverage of 
       lung cancer biomarker testing under the Medicaid program.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                           November 28, 2025

    Mr. Gottheimer (for himself and Mr. Rutherford) introduced the 
   following bill; which was referred to the Committee on Energy and 
                                Commerce

_______________________________________________________________________

                                 A BILL


 
 To amend title XIX of the Social Security Act to require coverage of 
       lung cancer biomarker testing under the Medicaid program.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Improving Medicaid Precision and 
Cancer Test Act of 2025''.

SEC. 2. REQUIRING COVERAGE OF LUNG CANCER BIOMARKER TESTING UNDER THE 
              MEDICAID PROGRAM.

    (a) In General.--Title XIX of the Social Security Act (42 U.S.C. 
1396 et seq.) is amended--
            (1) in section 1902(a)(10)(A), in the matter preceding 
        clause (i), by striking ``and (30)'' and inserting ``(30), and 
        (32)'';
            (2) in section 1905--
                    (A) in subsection (a)--
                            (i) in paragraph (31), by striking ``; 
                        and'' and inserting a semicolon;
                            (ii) by redesignating paragraph (32) as 
                        paragraph (33); and
                            (iii) by inserting the following paragraph 
                        after paragraph (31):
            ``(32) lung cancer biomarker testing; and''; and
            (3) in section 1937(b)(5), by inserting before the period 
        at the end the following: ``, and beginning January 1, 2027, 
        coverage of lung cancer biomarker testing''.
    (b) Effective Date.--The amendments made by this section shall 
apply beginning January 1, 2027.
                                 <all>